Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2.

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.

Gentile M, Shanafelt TD, Mauro FR, Reda G, Rossi D, Laurenti L, Del Principe MI, Cutrona G, Angeletti I, Coscia M, Herishanu Y, Chiarenza A, Molica S, Ciolli S, Goldschmidt N, Angrilli F, Giordano A, Rago A, Bairey O, Tripepi G, Chaffee KG, Sameer PA, Vigna E, Zirlik K, Shvidel L, Innocenti I, Recchia AG, Di Raimondo F, Del Poeta G, Cortelezzi A, Neri A, Ferrarini M, Gaidano G, Kay NE, Polliack A, Foà R, Morabito F.

Eur J Haematol. 2018 Jul 24. doi: 10.1111/ejh.13149. [Epub ahead of print] No abstract available.

PMID:
30039576
3.

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.

Morabito F, Shanafelt TD, Gentile M, Reda G, Mauro FR, Rossi D, Di Renzo N, Molica S, Angrilli F, Chiarenza A, Cutrona G, Chaffee KG, Parikh SA, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Cortelezzi A, Gaidano G, Di Raimondo F, Fais F, Foà R, Neri A, Ferrarini M.

Am J Hematol. 2018 Sep;93(9):E216-E219. doi: 10.1002/ajh.25206. Epub 2018 Jul 30. No abstract available.

4.

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.

Ambrosio MR, Lazzi S, Bello GL, Santi R, Porro LD, de Santi MM, Guazzo R, Mundo L, Rigacci L, Kovalchuck S, Onyango N, Fabbri A, Cencini E, Zinzani PL, Zaja F, Angrilli F, Stelitano C, Cabras MG, Spataro G, Bob R, Menter T, Granai M, Cevenini G, Naresh KN, Stein H, Sabattini E, Leoncini L.

Haematologica. 2019 Jan;104(1):e25-e28. doi: 10.3324/haematol.2018.195958. Epub 2018 Jun 28. No abstract available.

5.

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.

Gentile M, Shanafelt TD, Reda G, Mauro FR, Zirlik K, Ciolli S, Laurenti L, Del Principe MI, Rossi D, Di Renzo N, Molica S, Angrilli F, Coscia M, Chiarenza A, Giordano A, Cutrona G, Chaffee KG, Parikh SA, Uccello G, Innocenti I, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Herishanu Y, Shvidel L, Tadmor T, Cortelezzi A, Del Poeta G, Gaidano G, Di Raimondo F, Neri A, Ferrarini M, Foà R, Polliack A, Morabito F.

Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20. No abstract available.

PMID:
29588545
6.

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.

Luminari S, Ferrari A, Manni M, Dondi A, Chiarenza A, Merli F, Rusconi C, Tarantino V, Tucci A, Vitolo U, Kovalchuk S, Angelucci E, Pulsoni A, Arcaini L, Angrilli F, Gaidano G, Stelitano C, Bertoldero G, Cascavilla N, Salvi F, Ferreri AJM, Vallisa D, Marcheselli L, Federico M.

J Clin Oncol. 2018 Mar 1;36(7):689-696. doi: 10.1200/JCO.2017.74.1652. Epub 2017 Nov 2.

PMID:
29095677
7.

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).

Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

PMID:
29054815
8.

Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study.

Ricciuti G, Finolezzi E, Luciani S, Ranucci E, Federico M, Di Nicola M, Zecca IAL, Angrilli F.

Hematol Oncol. 2018 Feb;36(1):44-48. doi: 10.1002/hon.2386. Epub 2017 Feb 3.

PMID:
28156055
9.

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.

Bari A, Marcheselli R, Marcheselli L, Alvarez I, Pozzi S, Ferri P, Lazzaro A, Fragasso A, Neri S, Baldini L, Carella AM, Angrilli F, Guariglia R, Buda G, Stelitano C, Sacchi S; Gruppo Italiano Studio Linfomi (GISL).

Acta Haematol. 2017;137(1):7-14. doi: 10.1159/000449052. Epub 2016 Nov 4.

10.

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

Molica S, Shanafelt TD, Giannarelli D, Gentile M, Mirabelli R, Cutrona G, Levato L, Di Renzo N, Di Raimondo F, Musolino C, Angrilli F, Famà A, Recchia AG, Chaffee KG, Neri A, Kay NE, Ferrarini M, Morabito F.

Am J Hematol. 2016 Nov;91(11):1090-1095. doi: 10.1002/ajh.24493. Epub 2016 Aug 8.

11.

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

Gentile M, Zirlik K, Ciolli S, Mauro FR, Di Renzo N, Mastrullo L, Angrilli F, Molica S, Tripepi G, Giordano A, Di Raimondo F, Selleri C, Coscia M, Musso M, Orsucci L, Mannina D, Rago A, Giannotta A, Ferrara F, Herishanu Y, Shvidel L, Tadmor T, Scortechini I, Ilariucci F, Murru R, Guarini A, Musuraca G, Mineo G, Vincelli I, Arcari A, Tarantini G, Caparrotti G, Chiarenza A, Levato L, Villa MR, De Paolis MR, Zinzani PL, Polliack A, Morabito F.

Eur J Cancer. 2016 Jun;60:154-65. doi: 10.1016/j.ejca.2016.03.069. Epub 2016 Apr 27.

PMID:
27127905
12.

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.

Merli F, Luminari S, Gobbi PG, Cascavilla N, Mammi C, Ilariucci F, Stelitano C, Musso M, Baldini L, Galimberti S, Angrilli F, Polimeno G, Scalzulli PR, Ferrari A, Marcheselli L, Federico M.

J Clin Oncol. 2016 Apr 10;34(11):1175-81. doi: 10.1200/JCO.2015.62.4817. Epub 2015 Dec 28.

PMID:
26712220
13.

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

Gentile M, Shanafelt TD, Cutrona G, Molica S, Tripepi G, Alvarez I, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Vigna E, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Arcari A, Federico M, Mannina D, Recchia AG, Neri A, Kay NE, Ferrarini M, Morabito F.

Leukemia. 2016 Jun;30(6):1440-3. doi: 10.1038/leu.2015.333. Epub 2015 Dec 9. No abstract available.

PMID:
26648537
14.

Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Molica S, Ilariucci F, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Lionetti M, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Musto P, Federico M, Neri A, Ferrarini M, Morabito F.

Eur J Haematol. 2016 Jan;96(1):36-45. doi: 10.1111/ejh.12545. Epub 2015 Mar 31.

PMID:
25753656
15.

Cometary science. Dust measurements in the coma of comet 67P/Churyumov-Gerasimenko inbound to the Sun.

Rotundi A, Sierks H, Della Corte V, Fulle M, Gutierrez PJ, Lara L, Barbieri C, Lamy PL, Rodrigo R, Koschny D, Rickman H, Keller HU, López-Moreno JJ, Accolla M, Agarwal J, A'Hearn MF, Altobelli N, Angrilli F, Barucci MA, Bertaux JL, Bertini I, Bodewits D, Bussoletti E, Colangeli L, Cosi M, Cremonese G, Crifo JF, Da Deppo V, Davidsson B, Debei S, De Cecco M, Esposito F, Ferrari M, Fornasier S, Giovane F, Gustafson B, Green SF, Groussin O, Grün E, Güttler C, Herranz ML, Hviid SF, Ip W, Ivanovski S, Jerónimo JM, Jorda L, Knollenberg J, Kramm R, Kührt E, Küppers M, Lazzarin M, Leese MR, López-Jiménez AC, Lucarelli F, Lowry SC, Marzari F, Epifani EM, McDonnell JA, Mennella V, Michalik H, Molina A, Morales R, Moreno F, Mottola S, Naletto G, Oklay N, Ortiz JL, Palomba E, Palumbo P, Perrin JM, Rodríguez J, Sabau L, Snodgrass C, Sordini R, Thomas N, Tubiana C, Vincent JB, Weissman P, Wenzel KP, Zakharov V, Zarnecki JC.

Science. 2015 Jan 23;347(6220):aaa3905. doi: 10.1126/science.aaa3905.

16.

Cometary science. On the nucleus structure and activity of comet 67P/Churyumov-Gerasimenko.

Sierks H, Barbieri C, Lamy PL, Rodrigo R, Koschny D, Rickman H, Keller HU, Agarwal J, A'Hearn MF, Angrilli F, Auger AT, Barucci MA, Bertaux JL, Bertini I, Besse S, Bodewits D, Capanna C, Cremonese G, Da Deppo V, Davidsson B, Debei S, De Cecco M, Ferri F, Fornasier S, Fulle M, Gaskell R, Giacomini L, Groussin O, Gutierrez-Marques P, Gutiérrez PJ, Güttler C, Hoekzema N, Hviid SF, Ip WH, Jorda L, Knollenberg J, Kovacs G, Kramm JR, Kührt E, Küppers M, La Forgia F, Lara LM, Lazzarin M, Leyrat C, Lopez Moreno JJ, Magrin S, Marchi S, Marzari F, Massironi M, Michalik H, Moissl R, Mottola S, Naletto G, Oklay N, Pajola M, Pertile M, Preusker F, Sabau L, Scholten F, Snodgrass C, Thomas N, Tubiana C, Vincent JB, Wenzel KP, Zaccariotto M, Pätzold M.

Science. 2015 Jan 23;347(6220):aaa1044. doi: 10.1126/science.aaa1044.

17.

Cometary science. The morphological diversity of comet 67P/Churyumov-Gerasimenko.

Thomas N, Sierks H, Barbieri C, Lamy PL, Rodrigo R, Rickman H, Koschny D, Keller HU, Agarwal J, A'Hearn MF, Angrilli F, Auger AT, Barucci MA, Bertaux JL, Bertini I, Besse S, Bodewits D, Cremonese G, Da Deppo V, Davidsson B, De Cecco M, Debei S, El-Maarry MR, Ferri F, Fornasier S, Fulle M, Giacomini L, Groussin O, Gutierrez PJ, Güttler C, Hviid SF, Ip WH, Jorda L, Knollenberg J, Kramm JR, Kührt E, Küppers M, La Forgia F, Lara LM, Lazzarin M, Lopez Moreno JJ, Magrin S, Marchi S, Marzari F, Massironi M, Michalik H, Moissl R, Mottola S, Naletto G, Oklay N, Pajola M, Pommerol A, Preusker F, Sabau L, Scholten F, Snodgrass C, Tubiana C, Vincent JB, Wenzel KP.

Science. 2015 Jan 23;347(6220):aaa0440. doi: 10.1126/science.aaa0440.

18.

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

Rossi D, Bruscaggin A, La Cava P, Galimberti S, Ciabatti E, Luminari S, Rigacci L, Tucci A, Pulsoni A, Bertoldero G, Vallisa D, Rusconi C, Spina M, Arcaini L, Angrilli F, Stelitano C, Merli F, Gaidano G, Federico M, Palumbo GA.

Haematologica. 2015 Apr;100(4):517-24. doi: 10.3324/haematol.2014.108183. Epub 2015 Jan 16.

19.

Hairy cell leukaemia and venous thromboembolism: a case report and review of the literature.

Vazzana N, Spadano R, Sestili S, Toto V, Falorio S, Catinella V, Angrilli F, Dragani A.

Blood Transfus. 2014 Apr;12(2):276-9. doi: 10.2450/2014.0248-13. Review. No abstract available.

20.

Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Mosca L, Matis S, Fabris S, Lionetti M, Ilariucci F, Zupo S, Musolino C, Levato L, Molica S, Di Raimondo F, Vincelli I, Di Rienzo N, Pesce EA, Angrilli F, Federico M, Neri A, Ferrarini M, Morabito F.

Am J Hematol. 2014 Jul;89(7):743-50. doi: 10.1002/ajh.23729. Epub 2014 Apr 18.

21.

Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.

Mauro FR, Molica S, Laurenti L, Cortelezzi A, Carella AM, Zaja F, Chiarenza A, Angrilli F, Nobile F, Marasca R, Musolino C, Brugiatelli M, Piciocchi A, Vignetti M, Fazi P, Gentile G, De Propris MS, Della Starza I, Marinelli M, Chiaretti S, Del Giudice I, Nanni M, Albano F, Cuneo A, Guarini A, Foà R; Gruppo Italiano Malattie EMatologiche dell’Adulto Working Party for Chronic Lymphoproliferative Disorders.

Leuk Res. 2014 Feb;38(2):198-203. doi: 10.1016/j.leukres.2013.11.009. Epub 2013 Nov 19.

22.

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Fabris S, Pesce EA, Baldini L, Di Raimondo F, Musolino C, Di Tonno P, Di Renzo N, Molica S, Brugiatelli M, Ilariucci F, Zupo S, Matis S, Maura F, Vigna E, Angrilli F, Recchia AG, Quarta G, Iannitto E, Fragasso A, Musto P, Spriano M, Vincelli I, Vallisa D, Cortelezzi A, Mauro FR, Foà R, Federico M, Neri A, Ferrarini M, Morabito F.

Am J Hematol. 2013 Jul;88(7):539-44. doi: 10.1002/ajh.23448. Epub 2013 Jun 12.

23.

R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.

Federico M, Luminari S, Dondi A, Tucci A, Vitolo U, Rigacci L, Di Raimondo F, Carella AM, Pulsoni A, Merli F, Arcaini L, Angrilli F, Stelitano C, Gaidano G, Dell'olio M, Marcheselli L, Franco V, Galimberti S, Sacchi S, Brugiatelli M.

J Clin Oncol. 2013 Apr 20;31(12):1506-13. doi: 10.1200/JCO.2012.45.0866. Epub 2013 Mar 25. Erratum in: J Clin Oncol. 2014 Apr 1;32(10):1095. Dosage error in article text.

PMID:
23530110
24.

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.

Corazzelli G, Angrilli F, D'Arco A, Ferrara F, Musto P, Guarini A, Cox MC, Stelitano C, Storti S, Iannitto E, Falorio S, Califano C, Amore A, Arcamone M, De Filippi R, Pinto A.

Br J Haematol. 2013 Jan;160(2):207-15. doi: 10.1111/bjh.12120. Epub 2012 Nov 20.

PMID:
23167437
25.

Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.

Fabris S, Mosca L, Cutrona G, Lionetti M, Agnelli L, Ciceri G, Barbieri M, Maura F, Matis S, Colombo M, Gentile M, Recchia AG, Anna Pesce E, Di Raimondo F, Musolino C, Gobbi M, Di Renzo N, Mauro FR, Brugiatelli M, Ilariucci F, Lipari MG, Angrilli F, Consoli U, Fragasso A, Molica S, Festini G, Vincelli I, Cortelezzi A, Federico M, Morabito F, Ferrarini M, Neri A.

Am J Hematol. 2013 Jan;88(1):24-31. doi: 10.1002/ajh.23340. Epub 2012 Oct 9.

26.

Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.

Falorio S, Biasoli I, Luminari S, Quintana G, Musso M, Dell'olio M, Specchia MR, di Renzo N, Cesaretti M, Buda G, Vallisa D, Mannina D, Andriani A, Chiattone CS, Delamain MT, de Souza CA, Spector N, Angrilli F, Federico M.

Hematol Oncol. 2013 Jun;31(2):72-8. doi: 10.1002/hon.2029. Epub 2012 Oct 2. Erratum in: Hematol Oncol. 2013 Spe;31(3):167.

PMID:
23027689
27.

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.

Merli F, Luminari S, Ilariucci F, Petrini M, Visco C, Ambrosetti A, Stelitano C, Caracciolo F, Di Renzo N, Angrilli F, Carella AM, Capodanno I, Barbolini E, Galimberti S, Federico M.

Br J Haematol. 2012 Feb;156(3):346-53. doi: 10.1111/j.1365-2141.2011.08958.x. Epub 2011 Dec 7.

PMID:
22145911
28.

Images of asteroid 21 Lutetia: a remnant planetesimal from the early Solar System.

Sierks H, Lamy P, Barbieri C, Koschny D, Rickman H, Rodrigo R, A'Hearn MF, Angrilli F, Barucci MA, Bertaux JL, Bertini I, Besse S, Carry B, Cremonese G, Da Deppo V, Davidsson B, Debei S, De Cecco M, De Leon J, Ferri F, Fornasier S, Fulle M, Hviid SF, Gaskell RW, Groussin O, Gutierrez P, Ip W, Jorda L, Kaasalainen M, Keller HU, Knollenberg J, Kramm R, Kührt E, Küppers M, Lara L, Lazzarin M, Leyrat C, Lopez Moreno JJ, Magrin S, Marchi S, Marzari F, Massironi M, Michalik H, Moissl R, Naletto G, Preusker F, Sabau L, Sabolo W, Scholten F, Snodgrass C, Thomas N, Tubiana C, Vernazza P, Vincent JB, Wenzel KP, Andert T, Pätzold M, Weiss BP.

Science. 2011 Oct 28;334(6055):487-90. doi: 10.1126/science.1207325.

29.

Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma.

Gobbi PG, Valentino F, Bassi E, Coriani C, Merli F, Bonfante V, Marchianò A, Gallamini A, Bolis S, Stelitano C, Levis A, Federico M, Angrilli F, Di Giulio G, Corazza GR.

Clin Lymphoma Myeloma Leuk. 2011 Oct;11(5):396-402. doi: 10.1016/j.clml.2011.04.008. Epub 2011 Jun 12.

PMID:
21729691
30.

The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis.

Isidori A, Merli F, Angrilli F, Ferrara F, Alesiani F, Visani G.

Leuk Lymphoma. 2011 Jan;52(1):148-9. doi: 10.3109/10428194.2010.525726. Epub 2010 Nov 11. No abstract available.

PMID:
21067442
31.

E-type asteroid (2867) Steins as imaged by OSIRIS on board Rosetta.

Keller HU, Barbieri C, Koschny D, Lamy P, Rickman H, Rodrigo R, Sierks H, A'Hearn MF, Angrilli F, Barucci MA, Bertaux JL, Cremonese G, Da Deppo V, Davidsson B, De Cecco M, Debei S, Fornasier S, Fulle M, Groussin O, Gutierrez PJ, Hviid SF, Ip WH, Jorda L, Knollenberg J, Kramm JR, Kührt E, Küppers M, Lara LM, Lazzarin M, Lopez Moreno J, Marzari F, Michalik H, Naletto G, Sabau L, Thomas N, Wenzel KP, Bertini I, Besse S, Ferri F, Kaasalainen M, Lowry S, Marchi S, Mottola S, Sabolo W, Schröder SE, Spjuth S, Vernazza P.

Science. 2010 Jan 8;327(5962):190-3. doi: 10.1126/science.1179559.

32.

Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy.

Falorio S, Angrilli F, Fioritoni G.

Intern Med J. 2009 Oct;39(10):706-7. doi: 10.1111/j.1445-5994.2009.02027.x. No abstract available.

PMID:
19849763
33.

Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.

Iannitto E, Minardi V, Gobbi PG, Calvaruso G, Tripodo C, Marcheselli L, Luminari S, Merli F, Baldini L, Stelitano C, Callea V, Petrini M, Angrilli F, Quarta G, Vallisa D, Molica S, Liardo E, Polimeno G, Brugiatelli M, Federico M.

Clin Lymphoma Myeloma. 2009 Apr;9(2):138-44. doi: 10.3816/CLM.2009.n.034.

PMID:
19406724
34.

Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.

Luminari S, Marcheselli L, Sacchi S, Pozzi S, Bari A, Ilariucci F, Stelitano C, Angrilli F, Lazzaro A, Baldini L.

Cancer. 2009 May 1;115(9):1906-13. doi: 10.1002/cncr.24222.

35.

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

Federico M, Luminari S, Iannitto E, Polimeno G, Marcheselli L, Montanini A, La Sala A, Merli F, Stelitano C, Pozzi S, Scalone R, Di Renzo N, Musto P, Baldini L, Cervetti G, Angrilli F, Mazza P, Brugiatelli M, Gobbi PG; HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

J Clin Oncol. 2009 Feb 10;27(5):805-11. doi: 10.1200/JCO.2008.17.0910. Epub 2009 Jan 5.

PMID:
19124807
36.

Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.

Sacchi S, Marcheselli L, Bari A, Marcheselli R, Pozzi S, Gobbi PG, Angrilli F, Brugiatelli M, Musto P, Federico M.

Haematologica. 2008 Sep;93(9):1335-42. doi: 10.3324/haematol.12918. Epub 2008 Aug 12.

37.
38.

A dynamic upper atmosphere of Venus as revealed by VIRTIS on Venus Express.

Drossart P, Piccioni G, Gérard JC, Lopez-Valverde MA, Sanchez-Lavega A, Zasova L, Hueso R, Taylor FW, Bézard B, Adriani A, Angrilli F, Arnold G, Baines KH, Bellucci G, Benkhoff J, Bibring JP, Blanco A, Blecka MI, Carlson RW, Coradini A, Di Lellis A, Encrenaz T, Erard S, Fonti S, Formisano V, Fouchet T, Garcia R, Haus R, Helbert J, Ignatiev NI, Irwin P, Langevin Y, Lebonnois S, Luz D, Marinangeli L, Orofino V, Rodin AV, Roos-Serote MC, Saggin B, Stam DM, Titov D, Visconti G, Zambelli M, Tsang C; VIRTIS-Venus Express Technical Team, Ammannito E, Barbis A, Berlin R, Bettanini C, Boccaccini A, Bonnello G, Bouyé M, Capaccioni F, Cardesin A, Carraro F, Cherubini G, Cosi M, Dami M, De Nino M, Del Vento D, Di Giampietro M, Donati A, Dupuis O, Espinasse S, Fabbri A, Fave A, Veltroni IF, Filacchione G, Garceran K, Ghomchi Y, Giustizi M, Gondet B, Hello Y, Henry F, Hofer S, Huntzinger G, Kachlicki J, Knoll R, Kouach D, Mazzoni A, Melchiorri R, Mondello G, Monti F, Neumann C, Nuccilli F, Parisot J, Pasqui C, Perferi S, Peter G, Piacentino A, Pompei C, Réess JM, Rivet JP, Romano A, Russ N, Santoni M, Scarpelli A, Sémery A, Soufflot A, Stefanovitch D, Suetta E, Tarchi F, Tonetti N, Tosi F, Ulmer B.

Nature. 2007 Nov 29;450(7170):641-5.

39.

South-polar features on Venus similar to those near the north pole.

Piccioni G, Drossart P, Sanchez-Lavega A, Hueso R, Taylor FW, Wilson CF, Grassi D, Zasova L, Moriconi M, Adriani A, Lebonnois S, Coradini A, Bézard B, Angrilli F, Arnold G, Baines KH, Bellucci G, Benkhoff J, Bibring JP, Blanco A, Blecka MI, Carlson RW, Di Lellis A, Encrenaz T, Erard S, Fonti S, Formisano V, Fouchet T, Garcia R, Haus R, Helbert J, Ignatiev NI, Irwin PG, Langevin Y, Lopez-Valverde MA, Luz D, Marinangeli L, Orofino V, Rodin AV, Roos-Serote MC, Saggin B, Stam DM, Titov D, Visconti G, Zambelli M; VIRTIS-Venus Express Technical Team, Ammannito E, Barbis A, Berlin R, Bettanini C, Boccaccini A, Bonnello G, Bouye M, Capaccioni F, Moinelo AC, Carraro F, Cherubini G, Cosi M, Dami M, De Nino M, Del Vento D, Di Giampietro M, Donati A, Dupuis O, Espinasse S, Fabbri A, Fave A, Veltroni IF, Filacchione G, Garceran K, Ghomchi Y, Giustini M, Gondet B, Hello Y, Henry F, Hofer S, Huntzinger G, Kachlicki J, Knoll R, Driss K, Mazzoni A, Melchiorri R, Mondello G, Monti F, Neumann C, Nuccilli F, Parisot J, Pasqui C, Perferi S, Peter G, Piacentino A, Pompei C, Reess JM, Rivet JP, Romano A, Russ N, Santoni M, Scarpelli A, Semery A, Soufflot A, Stefanovitch D, Suetta E, Tarchi F, Tonetti N, Tosi F, Ulmer B.

Nature. 2007 Nov 29;450(7170):637-40.

PMID:
18046395
40.

Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.

Sacchi S, Pozzi S, Marcheselli L, Bari A, Luminari S, Angrilli F, Merli F, Vallisa D, Baldini L, Brugiatelli M; Italian Lymphoma Study Group.

Cancer. 2007 May 15;109(10):2077-82.

41.

Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.

Pozzi S, Marcheselli R, Sacchi S, Baldini L, Angrilli F, Pennese E, Quarta G, Stelitano C, Caparotti G, Luminari S, Musto P, Natale D, Broglia C, Cuoghi A, Dini D, Di Tonno P, Leonardi G, Pianezze G, Pitini V, Polimeno G, Ponchio L, Masini L, Musso M, Spriano M, Pollastri G; Gruppo Italiano Studio Linfomi.

Leuk Lymphoma. 2007 Jan;48(1):56-64.

PMID:
17325848
42.

The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).

Morabito F, Stelitano C, Luminari S, Mammi C, Marcheselli L, Callea V, Gentile M, Polimeno G, Merli F, Molica S, Gobbi P, Angrilli F, Brugiatelli M, Federico M.

Bone Marrow Transplant. 2006 Feb;37(3):283-8.

PMID:
16327815
43.

In situ measurements of the physical characteristics of Titan's environment.

Fulchignoni M, Ferri F, Angrilli F, Ball AJ, Bar-Nun A, Barucci MA, Bettanini C, Bianchini G, Borucki W, Colombatti G, Coradini M, Coustenis A, Debei S, Falkner P, Fanti G, Flamini E, Gaborit V, Grard R, Hamelin M, Harri AM, Hathi B, Jernej I, Leese MR, Lehto A, Lion Stoppato PF, López-Moreno JJ, Mäkinen T, McDonnell JA, McKay CP, Molina-Cuberos G, Neubauer FM, Pirronello V, Rodrigo R, Saggin B, Schwingenschuh K, Seiff A, Simões F, Svedhem H, Tokano T, Towner MC, Trautner R, Withers P, Zarnecki JC.

Nature. 2005 Dec 8;438(7069):785-91. Epub 2005 Nov 30.

PMID:
16319827
44.

Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).

Lombardo M, Morabito F, Merli F, Molica S, Cavanna L, Sacchi S, Broglia C, Angrilli F, Ilariucci F, Stelitano C, Luisi D, Bertè R, Luminari S, Federico M, Brugiatelli M; GISL.

Leuk Lymphoma. 2002 Sep;43(9):1795-801.

PMID:
12685834
46.

Euthyroid sick syndrome in children with Hodgkin disease.

Mohn A, Di Marzio A, Cerruto M, Angrilli F, Fioritoni C, Chiarelli F.

Pediatr Hematol Oncol. 2001 Apr-May;18(3):211-5.

PMID:
11293290
47.

Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.

Gobbi PG, Broglia C, Bertè R, Petrilli MP, Molica S, Angrilli F, Iannitto E, Ghirardelli ML, Di Renzo N, Cavanna L, Ascari E.

Haematologica. 2000 Jul;85(7):722-8.

48.

Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.

Stelitano C, Baldini L, Pieresca C, Callea V, Angrilli F, Clò V, Partesotti G, Merli F, Cavanna L, Morabito F, Federico M, Brugiatelli M, Silingardi V.

Haematologica. 2000 Feb;85(2):154-9.

49.

Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).

Longo G, Fiorani C, Sacchi S, Callea V, Lombardo M, Federico M, Stelitano C, Angrilli F, Vallisa D, Gobbi PG, Ilariucci F, Frassoldati A, Petrini M, Silingardi V.

Haematologica. 1999 May;84(5):425-30.

50.

Thyroid function in children treated for acute lymphoblastic leukemia.

Mohn A, Chiarelli F, Di Marzio A, Impicciatore P, Marsico S, Angrilli F.

J Endocrinol Invest. 1997 Apr;20(4):215-9. Review.

PMID:
9211129

Supplemental Content

Loading ...
Support Center